CACNB2

CACNB2 encodes the CaVβ2 auxiliary subunit of L-type voltage-gated calcium channels, where it controls L-type calcium current and channel inactivation kinetics in cardiomyocytes (PMID:21357697, PMID:24752249). Its functional importance is developmentally staged: embryonic cardiomyocyte deletion is lethal with up to 75% loss of L-type current, whereas conditional excision in adult myocytes reduces current density by less than 29% without compensatory CaVβ upregulation or loss of CaV1.2 protein, indicating a moderate modulatory role in mature heart (PMID:21357697). As a MAGUK-family scaffold with conserved SH3 and guanylate kinase domains, CACNB2 also maintains N-cadherin-based adherens junctions and supports cardiac contractility, proliferation, and chamber morphogenesis, phenotypes that are at least partly dependent on L-type channel activity (PMID:22274990, PMID:18419826). Beyond its channel-associated functions, CACNB2 drives cell proliferation through the RAS-MAPK pathway independently of channel activity (PMID:30992131) and attenuates atrial fibrosis via modulation of TGF-β/Smad signaling (PMID:41748049). CACNB2 expression is post-transcriptionally repressed by miR-499/miR-499-5p binding to its 3' UTR—reducing CaV1.2 surface expression in both cardiomyocytes and neurons—and is silenced by promoter hypermethylation, with allele-specific promoter variants further tuning its expression (PMID:28239561, PMID:35969184, PMID:35894107, PMID:23744328). Disease-associated missense variants alter channel inactivation and cause loss-of-function, linking CACNB2 to short QT syndrome (S480L) and Brugada syndrome (S142F), with isogenic CRISPR correction rescuing the electrophysiological defects (PMID:35894107, PMID:35955449).

1. 2008 Medium

   Establishing that CACNB2 is a MAGUK-family protein with defined modular architecture framed it as more than a simple channel modulator, raising the possibility of scaffolding functions.

   Evidence cDNA cloning, sequence analysis, and RT-PCR of zebrafish and human loci

   PMID:18419826

   Open questions at the time

   • Domain architecture inferred from sequence without functional assignment of SH3/GK domains
   • Functional consequence of alternative splice variants not tested
2. 2011 High

   Conditional adult cardiomyocyte knockout resolved whether CACNB2 is essential throughout life, showing its requirement for L-type current is developmentally staged—critical in embryo, only moderately modulatory in adult.

   Evidence Cre-lox conditional knockout with patch-clamp and protein quantification in adult mouse cardiomyocytes

   PMID:21357697

   Open questions at the time

   • Mechanism of the embryonic-to-adult shift in dependence unresolved
   • Why no compensatory CaVβ upregulation occurs not explained
3. 2012 High

   Zebrafish loss-of-function dissected channel-dependent versus scaffolding roles, showing CACNB2 maintains N-cadherin adherens junctions and supports contractility, proliferation, and chamber morphogenesis.

   Evidence Morpholino knockdown with pharmacological LTCC modulation/rescue and N-cadherin immunostaining in zebrafish

   PMID:22274990

   Open questions at the time

   • Direct physical interaction of CACNB2 with N-cadherin complex not mapped
   • Extent to which scaffolding is separable from channel function not quantified
4. 2013 Medium

   Allele-specific promoter reporter assays established that regulatory-region variants tune CACNB2 transcription, introducing expression-level control as a disease-relevant variable.

   Evidence Luciferase reporter assay of CACNB2 promoter fragment carrying rs7069292

   PMID:23744328

   Open questions at the time

   • In vivo physiological consequence of allele-specific expression not shown
   • Transcription factors mediating allelic difference unidentified
5. 2014 High

   Recombinant electrophysiology of ASD-associated missense variants showed CACNB2 mutations alter channel inactivation kinetics, providing a biophysical basis for variant pathogenicity.

   Evidence Site-directed mutagenesis and whole-cell patch-clamp in HEK-293 cells

   PMID:24752249

   Open questions at the time

   • Phenotypic relevance in neurons or patients not demonstrated
   • Single heterologous system without native cell context
6. 2017 High

   Identification of direct miR-499 binding to the CACNB2 3' UTR revealed a post-transcriptional control layer that also lowers the pore-forming CACNA1C subunit.

   Evidence Luciferase reporter, Argonaute pull-down, and bidirectional miRNA manipulation in HL-1 cardiomyocytes

   PMID:28239561

   Open questions at the time

   • Physiological contexts where miR-499 regulates CACNB2 in vivo not defined
   • Mechanism by which CACNB2 loss reduces CACNA1C protein not established
7. 2019 Medium

   Overexpression experiments uncovered a channel-independent function, showing CACNB2 drives proliferation through RAS-MAPK without requiring LTCC activity.

   Evidence HEK293 overexpression with nifedipine dissection and Dahl Salt-Sensitive rat kidney expression analysis

   PMID:30992131

   Open questions at the time

   • Mechanistic link to RAS-MAPK is correlative without direct pathway reconstitution
   • Direct molecular partner connecting CACNB2 to RAS-MAPK unidentified
8. 2019 Low

   Pharmacological work in retinal pigment epithelial cells extended CACNB2-containing channels to VEGF secretion, implicating them in proliferative diabetic retinopathy.

   Evidence Pharmacological LTCC blockade and VEGF measurement in ARPE19 cells

   PMID:31439644

   Open questions at the time

   • CACNB2-specific role not isolated from general LTCC activity
   • Single cell line, no loss-of-function for CACNB2 itself
9. 2022 High

   Patient-derived hiPSC-CM models with isogenic CRISPR correction established CACNB2 missense variants (S142F, S480L) as causative loss-of-function alleles in Brugada and short QT syndromes, and identified promoter hypermethylation as an additional silencing mechanism.

   Evidence hiPSC-CM generation, CRISPR/Cas9 isogenic correction, patch-clamp, bisulfite sequencing, and demethylase rescue

   PMID:35894107 PMID:35955449

   Open questions at the time

   • Trigger for promoter hypermethylation and DNMT upregulation unknown
   • Generalizability across patient backgrounds not established
10. 2022 High

    Neuronal studies generalized miR-499-5p repression of CACNB2 beyond heart, showing it reduces CaV1.2 surface expression and impairs dendritogenesis and memory in a Cacna1c-dependent manner.

    Evidence miRNA overexpression in rat hippocampal neurons in vitro and in vivo with genetic epistasis against Cacna1c haploinsufficiency and behavioral testing

    PMID:35969184

    Open questions at the time

    • Direct biochemical mechanism linking CACNB2 loss to dendritic deficits not resolved
    • Whether scaffolding versus channel role drives the neuronal phenotype unclear
11. 2026 Medium

    An atrial fibrillation rat model defined a fibrosis-protective role, with CACNB2 overexpression attenuating Ang II profibrotic signaling through modulation of the TGF-β/Smad pathway.

    Evidence In vivo rat AF overexpression model plus primary atrial fibroblast/cardiomyocyte assays with TGF-β/Smad western blotting

    PMID:41748049

    Open questions at the time

    • Link to TGF-β/Smad is correlative without direct pathway reconstitution
    • Whether the antifibrotic effect requires channel activity not tested

• How CACNB2's channel-dependent and channel-independent (RAS-MAPK, TGF-β/Smad, scaffolding) functions are molecularly partitioned and co-regulated remains unresolved.
• No direct physical partner identified for the RAS-MAPK or TGF-β/Smad effects
• Structural basis distinguishing channel modulation from scaffolding not established
• Tissue-specific balance of the multiple functions not mapped